Jennison Associates LLC

Jennison Associates LLC

Jennison Associates LLC

Date Founded



466 Lexington Avenue,New York, NY 10017-3140

Type of Company


Employees (Worldwide)



Investment Services & Portfolio Management
Hospitals & Patient Services
Private Equity & Venture Capital

Company Description

Jennison Associates has expertise in a range of equity strategies across styles and market-caps, as well as fixed income strategies. The firm manages portfolios based on internal fundamental research, bottom-up security selection and a highly interactive investment process. Jennison Associates specializes in fundamental analysis, which involves attempting to gain insight into the future value of a company by studying company-specific and market-related quantitative (such as financial statements) and qualitative (such as quality of company management or products) information. Although portfolio managers ultimately make investment decisions for the portfolios they manage, they work closely with research analysts and other portfolio managers in a dynamic and continuous process of updating and debating investment ideas and company-specific convictions. They use quantitative tools to create and manage some of their customized equity portfolios and their quantitatively hedged portfolios.

Contact Data
Trying to get in touch with decision makers at Jennison Associates LLC? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founder, President & Chief Investment Officer

Chairman of the Board & Chief Executive Officer

Senior Vice President & Chief Financial Officer

Executive Vice President, Treasurer & Chief Operating Officer

Chief Risk Officer

Senior Vice President, Secretary & Chief Legal Officer


Managing Director & Head of Growth Equity

Managing Director, Head of Small & Mid Cap Equity

Managing Director & Head of Value Equity

Board of Directors

Chairman of the Board & Chief Executive Officer at Jennison Associates LLC

Chairman & Chief Executive Officer at Prudential Financial, Inc.

Vice President US Businesses & Head of Human Resources at Prudential Financial, Inc.

President & Chief Executive Officer at PGIM, Inc.

Founder, President & Chief Investment Officer at Jennison Associates LLC

Corporate Vice President & Head of Human Resources at PGIM, Inc.

Managing Director & Head of Growth Equity at Jennison Associates LLC

Chief Compliance Officer & Managing Director at Morgan Stanley Investment Management, Inc.

Board Member at Jennison Associates LLC

Paths to Jennison Associates LLC
Potential Connections via
Relationship Science
Jennison Associates LLC
Advisors & Consultants

Deloitte & Touche LLP engages in the provision of auditing and consulting services. It also provides accounting, financial advisory, risk management, and tax services. Its services include international financial reporting, assurance, advisory, tax auditing, corporate governance, risk consulting, advisory services, mergers and acquisitions, government compliance, and human capital consulting services. Deloitte & Touche was founded on March 7, 1995 and is headquartered in New York, NY.


Goldman, Sachs & Co. (GS&Co.), a limited partnership registered as a U.S. broker-dealer and futures commission merchant, together with its consolidated subsidiaries (collectively, the firm), is an indirectly wholly owned subsidiary of The Goldman Sachs Group, Inc. (Group Inc.), a Delaware corporation. The firm is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals.


PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.


Braille Institute of America, Inc. offers different services to people with vision loss. The company was founded by J. Robert Atkinson in 1919 and is headquartered in Los Angles, CA.

URS focuses on strategic, long-term investments across a wide variety of asset classes including domestic equities, international equities, domestic fixed-income securities, international fixed-income securities, domestic short-term securities, international short-term, absolute return strategies, private equity, real estate and mortgage loans. Their primary investment objectives are to preserve fund assets and generate an appropriate level of risk-adjusted return to meet future pension obligations. URS periodically completes an asset allocation and liability study to determine the optimal portfolio diversification to meet those obligations. URS maintains a long-term investment outlook to allow the portfolio to take advantage of the favorable risk-return characteristics of equities by placing more emphasis on this category. Internal and external portfolio managers employing both passive (indexed) and active strategies are utilized.

TRS' Internal Investment Committee (IIC) approves investments in private equity, real estates, hedge funds and external managers. The firm's investment performance is calculated using a daily time weighted rate of return. Investment decisions are based on asset allocation, which is determined after consideration of expected returns for asset classes with the context of risk tolerance for the fund. TRS uses both passive and active investing styles. Their approach tracks the performance of key benchmarks and provides the opportunity to add value through active portfolios. TRS' style is a disciplined, balanced approach with a strong quantitative foundation that focuses on long-term returns and objectives rather than on short-term market movements. The process includes frequent updating of statistical risk and return models constructed by TRS' investment staff.

Details Hidden

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, and Joshua A. Kazam on November 2017 and is headquartered in South San Francisco, CA.

Details Hidden

Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of oncology therapies. The company focuses on disabling cancer's ability to subvert immune attack by inhibiting adenosine in the tumor microenvironment and by blocking its production by tumors. Its product pipeline includes Adenosine A2A Receptor Antagonist CPI-444, Adenosine Production Inhibitor Anti-CD73, Adenosine A2B Receptor Antagonist, ITK Inhibitor, and Myeloid Cell Suppression. The company was founded by Richard A. Miller, Peter A. Thompson, and Joseph J. Buggy on January 27, 2014 and is headquartered in Burlingame, CA.

Details Hidden

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jennison Associates LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jennison Associates LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Jennison Associates LLC.
  • be_ixf; php_sdk; php_sdk_1.4.15